Dissociation of EBV genome replication and host cell proliferation in anti-IgG-stimulated Akata cells

Clinical Immunology and Immunopathology

Volumn 81, Issue 2, 1996, Pages 168-174

  Takase, Kozo ^a   Kelleher, Colm A ^a   Terada, Naohiro ^a   Jones, James F ^a   Lucas, Joseph J ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DIMETHYL SULFOXIDE; IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION;

EID: 0030296592     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0173     Document Type: Article

References (31)

1. 1. Miller, G., Epstein-Barr virus. In "Virology" (B. N. Fields and D. M. Knipe, Eds.), 2nd ed., pp. 1921-1958, Raven Press, New York, 1990.
2. 2. Fox, R., Epstein-Barr virus and human autoimmune diseases: Possibilities and pitfalls. J. Virol. Methods 21, 19-27, 1988.
3. 3. Fox, R. I., Luppi, M., Kang, H. I., and Pisa, P., Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Semin. Immunopathol. 13, 217-231, 1991.
4. 4. Logtenberg, T., Schutte, M. E., Ebeling, S. B., Gmelig, M. F., and van Es, J., Molecular approaches to the study of human B-cell and (auto) antibody repertoire generation and selection. Immunol. Rev. 128, 23-47, 1992.
5. 5. Sample, J., and Kieff, E., Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes. J. Virol. 64, 1667-1674, 1990.
6. 6. Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J., and Rickinson, A. B., Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349, 612-614, 1991.
7. 7. Henderson, S., Rowe, M., Gregory, C., Croom, C. D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A., Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115, 1991.
8. 8. Adams, A., Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61, 1743-1746, 1987.
9. 9. Faggioni, A., Zompetta, C., Grimaldi, S., Barile, G., Frati, L., and Lazdins, J., Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 232, 1554-1556, 1986.
10. 10. Gerber, P., Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells. Proc. Natl. Acad. Sci. USA 69, 83-85, 1972.
11. 11. Takada, K., Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33, 27-32, 1984.
12. 12. Takagi, S., Takada, K., and Sairenji, T., Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology 185, 309-315, 1991.
13. 13. Tovey, M. G., Lenoir, G., and Begon, L. J., Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276, 270-272, 1978.
14. 14. Manet, E., Gruffat, H., Trescol, B. M., Moreno, N., Chambard, P., Giot, J. F., and Sergeant, A., Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators. EMBO J. 8, 1819-1826, 1989.
15. 15. Le Roux, F., Sergeant, A., and Corbo, L., Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. J. Gen. Virol 77, 501-509, 1996.
16. 16. Raab-Traub, N., and Flynn, K., The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47, 883-889, 1986.
17. 17. Allaudeen, H. S., and Rani, G., Cellular and Epstein-Barr virus specific DNA polymerases in virus-producing Burkitt's lymphoma cell lines. Nucleic Acids Res. 10, 2453-2465, 1982.
18. 18. Datta, A. K., Colby, B. M., Shaw, J. E., and Pagano, J. S., Acyclovir inhibition of Epstein-Barr virus replication. Proc. Natl. Acad. Sci. USA 77, 5163-5166, 1980.
19. 19. Takada, K., Horinouchi, K., Ono, Y., Aya, T., Osato, T., Takahashi, M., and Hayasaka, S., An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes 5, 147-156, 1991.
20. 20. Takada, K., and Ono, Y., Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63, 445-449, 1989.
21. 21. Sawai, M., Takase, K., Teraoka, H., and Tsukada, K., Reversible G1 arrest in the cell cycle of human lymphoid cell lines by dimethyl sulfoxide. Exp. Cell. Res. 187, 4-10, 1990.
22. 22. Takase, K., Sawai, M., Yamamoto, K., Yata, J., Takasaki, Y., Teraoka, H., and Tsukada, K., Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: Kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells. Cell Growth Differ. 3, 515-521, 1992.
23. 23. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685, 1970.
24. 24. Mikaelian, I., Drouet, E., Marechal, V., Denoyel, G., Nicolas, J. C., and Sergeant, A., The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. J. Virol. 67, 734-742, 1993.
25. 25. Kiehl, A., and Dorsky, D. I., Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. Virology 184, 330-340, 1991.
26. 26. Pearson, G. R., Vroman, B., Chase, B., Sculley, T., Hummel, M., and Kieff, E., Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47, 193-201, 1983.
27. 27. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., and Rickinson, A., Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl Acad. Sci. USA 90, 8479-8483, 1993.
28. 28. Pearson, G. R., Luka, J., Petti, L., Sample, J., Birkenbach, M., Braun, D., and Kieff, E., Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160, 151-161, 1987.
29. 29. Takase, K., Iwaki, K., Gunji, T., and Yata, J., Fluorescence intensity analysis through simplex optimization in flow cytometry. J. Immunol. Methods 118, 129-138, 1989.
30. 30. Lin, J. C., Smith, M. C., and Pagano, J. S., Activation of latent Epstein-Barr virus genomes: Selective stimulation of synthesis of chromosomal proteins by a tumor promoter. J. Virol. 45, 985-991, 1983.
31. 31. Yajima, Y., and Nonoyama, M., Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells. J. Virol. 19, 187-194, 1976.